Breaking News

You are here » Indian-Commodity  :  Top News  :  Glenmark's arm gets USFDA's final approval for Clindamycin, Benzoyl Peroxide Gel

15-Mar2019

Glenmark's arm gets USFDA's final approval for Clindamycin, Benzoyl Peroxide Gel

Glenmark Pharmaceuticals' subsidiary -- Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Clindamycin and Benzoyl Peroxide Gel, 1%/5%, a generic version of BenzaClin Gel, 1%/5%, of Valeant Bermuda. According to IQVIA sales data for the 12 month period ending January 2019, the BenzaClin Gel, 1%/5% market achieved annual sales of approximately $99.4 million.

The company's current portfolio consists of 151 products authorized for distribution in the US marketplace and 53 ANDA's pending approval with the USFDA. In addition to these, the company continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).


Related News

View all news

Crude oil futures end lower on Friday

Crude oil futures ended lower on Friday on concerns about global energy demand. However, US prices managed to tally a gain for the week, their third in a row, as OPEC output cuts and US sanctions on Venezuela......

Gold futures finish higher on Friday

Gold futures finished higher on Friday, due to increased safe haven buying of market participants followed by subdued economic data from the euro zone, exacerbating global growth fears. Gold futures for......

Copper futures end lower on global growth concerns

Copper futures ended lower on Friday as weak European and US factory data spread gloom about the global economic outlook and strengthened the dollar. Reports showing Factory activity in the 19-country......

Top News

View all news

Infosys to enter into agreement with The House Fund II

Infosys is going to enter into an agreement with The House Fund II, L.P., an AI-focused fund targeting startups from the University of California - Berkeley, committing to invest $10.0 million.......

EID Parry receives approval for investment Rs 70 crore in PSRIPL

EID Parry (INDIA) has received approval for investment upto Rs 70 crore in the equity share capital of Parry Sugars Refinery India (PSRIPL), a wholly owned subsidiary of the Company. The Board of directors......

SBI raises Rs 1,251 crore by issuing Basel III-compliant bonds

State Bank of India (SBI) has raised Rs 1,251.30 crore by issuing Basel III-compliant bonds. The Committee of Directors for Capital Raising at its meeting held on 22 March 2019 deliberated and accorded......